ADAG Company Profile and Key Details
Adagene Inc.
ADAG Stock Price Chart
Stock Price Today
Adagene Inc. (ADAG) stock declined over -1.08%, trading at $1.84 on NASDAQ, down from the previous close of $1.86. The stock opened at $1.84, fluctuating between $1.84 and $1.84 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody, which is in preclinical; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical stage for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a CD20xCD3 POWERbody, which is in preclinical stage for the treatment off-tumor toxicities. The company was incorporated in 2011 and is headquartered in Suzhou, China.
Company Information
| Employees | 174 |
| Beta | 0.58 |
| Sales or Revenue | $18.11M |
| 5Y Sales Change% | 8.417% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Adagene Inc. (NASDAQ: ADAG) stock price is $1.84 in the last trading session. During the trading session, ADAG stock reached the peak price of $1.84 while $1.84 was the lowest point it dropped to. The percentage change in ADAG stock occurred in the recent session was -1.08% while the dollar amount for the price change in ADAG stock was -$0.02.
The NASDAQ listed ADAG is part of Biotechnology industry that operates in the broader Healthcare sector. Adagene Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Ami Celeste Knoefler
Vice President of Investor Relations & Corporation Communications
Dr. Peter P. Luo Ph.D.
Co- Founder, Chairman, Chief Executive Officer and Pres of R&D
Ms. Xiaohong She
Senior Vice President & Head of Clinical Operations
Dr. Jc Xu M.D., Ph.D.
Chief Scientific Officer
Dr. Fangyong Du Ph.D.
Chief Technology Officer & Director
Dr. Guizhong Liu Ph.D.
Head of Biology & Pharmacology
Ms. Ling Zhou
Head of HR
Mr. Man Kin Tam M.B.A.
Chief Financial Officer & Director
Dr. Qinghai Zhao
Chief Manufacturing Officer
Ms. Yan Li M.B.A.
Senior Vice President of Bioinformatics & Information Technology
ADAG's closing price is 6.9% higher than its 52-week low of $1.74 where as its distance from 52-week high of $3.80 is -51.05%.
Number of ADAG employees currently stands at 174.
Official Website of ADAG is: https://www.adagene.com
ADAG could be contacted at phone 865 128 7773632 and can also be accessed through its website. ADAG operates from Building C14, Suzhou, 215123, China.
ADAG stock volume for the day was 177 shares. The average number of ADAG shares traded daily for last 3 months was 102.08K.
The market value of ADAG currently stands at $81.46M with its latest stock price at $1.84 and 44.27M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com